Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide and cardiovascular outcomes in patients with obesity and established cardiovascular disease (SELECT trial)
HH: Conceptualization, Funding acquisition, Supervision, Writing review and editing
ISSN 0199-9885
PubMed pubmed.ncbi.nlm.nih.gov [38] Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity ScienceDirect [39] Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity ScienceDirect [40] A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point
US$ 25.64
US$ 25.21
US$ 28.77
